Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis

Table 3 Baseline data of the patients in the different risk groups

Variable	Derivation cohort			Validation cohort
	High risk	Low risk	P value	High risk	Low risk	P value
Sex			0.235			0.015
Female	116	129		96	122
Male	106	94		123	98
Age, yr			0. 742			0.416
< 65	101	98		102	111
≥ 65	121	125		117	109
TNM stage			0.001			0.017
Ι + Ⅱ	159	189		174	195
Ⅲ + Ⅳ	63	34		44	23
Unknown				1	2
T stage			0.002			< 0.001
T1	57	97		49	100
T2	132	102		142	106
T3	23	14		21	7
T4	9	8		6	5
Tx	1	2		1	2
Status			< 0.001			0.003
Surviving	116	159		87	119
Non-surviving	106	64		132	101

TNM: Tumor, node and metastasis.